BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 8754856)

  • 1. De novo methylation of CpG island sequences in human fibroblasts overexpressing DNA (cytosine-5-)-methyltransferase.
    Vertino PM; Yen RW; Gao J; Baylin SB
    Mol Cell Biol; 1996 Aug; 16(8):4555-65. PubMed ID: 8754856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilization of DNA methyltransferase levels and CpG island hypermethylation precede SV40-induced immortalization of human fibroblasts.
    Vertino PM; Issa JP; Pereira-Smith OM; Baylin SB
    Cell Growth Differ; 1994 Dec; 5(12):1395-402. PubMed ID: 7696189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation profiling of CpG islands in human breast cancer cells.
    Huang TH; Perry MR; Laux DE
    Hum Mol Genet; 1999 Mar; 8(3):459-70. PubMed ID: 9949205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retention of unmethylated CpG island alleles in human diploid fibroblast x fibrosarcoma hybrids expressing high levels of DNA methyltransferase.
    Kuerbitz SJ; Baylin SB
    Cell Growth Differ; 1996 Jun; 7(6):847-53. PubMed ID: 8780898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting aberrant CpG island methylation.
    Feltus FA; Lee EK; Costello JF; Plass C; Vertino PM
    Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12253-8. PubMed ID: 14519846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation.
    Graff JR; Herman JG; Myöhänen S; Baylin SB; Vertino PM
    J Biol Chem; 1997 Aug; 272(35):22322-9. PubMed ID: 9268383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation-mediated silencing of TMS1/ASC is accompanied by histone hypoacetylation and CpG island-localized changes in chromatin architecture.
    Stimson KM; Vertino PM
    J Biol Chem; 2002 Feb; 277(7):4951-8. PubMed ID: 11733524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methyltransferase levels and altered CpG methylation in the total genome and in the GSTP1 gene in human glioma cells transfected with sense and antisense DNA methyltransferase cDNA.
    Antoun G; Baylin SB; Ali-Osman F
    J Cell Biochem; 2000 Apr; 77(3):372-81. PubMed ID: 10760946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the cytosine DNA-methyltransferase and p16INK4a genes in the development of mouse lung tumors.
    Belinsky SA
    Exp Lung Res; 1998; 24(4):463-79. PubMed ID: 9659578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased cytosine DNA-methyltransferase activity during colon cancer progression.
    Issa JP; Vertino PM; Wu J; Sazawal S; Celano P; Nelkin BD; Hamilton SR; Baylin SB
    J Natl Cancer Inst; 1993 Aug; 85(15):1235-40. PubMed ID: 8331684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multifactorial signature of DNA sequence and polycomb binding predicts aberrant CpG island methylation.
    McCabe MT; Lee EK; Vertino PM
    Cancer Res; 2009 Jan; 69(1):282-91. PubMed ID: 19118013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant silencing of the CpG island-containing human O6-methylguanine DNA methyltransferase gene is associated with the loss of nucleosome-like positioning.
    Patel SA; Graunke DM; Pieper RO
    Mol Cell Biol; 1997 Oct; 17(10):5813-22. PubMed ID: 9315639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo CpG island methylation in human cancer cells.
    Jair KW; Bachman KE; Suzuki H; Ting AH; Rhee I; Yen RW; Baylin SB; Schuebel KE
    Cancer Res; 2006 Jan; 66(2):682-92. PubMed ID: 16423997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse DNA methyltransferase (MTase) deletion mutants that retain the catalytic domain display neither de novo nor maintenance methylation activity in vivo.
    Zimmermann C; Guhl E; Graessmann A
    Biol Chem; 1997 May; 378(5):393-405. PubMed ID: 9191026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methyl-CpG-binding protein MBD2 plays a key role in maintenance and spread of DNA methylation at CpG islands and shores in cancer.
    Stirzaker C; Song JZ; Ng W; Du Q; Armstrong NJ; Locke WJ; Statham AL; French H; Pidsley R; Valdes-Mora F; Zotenko E; Clark SJ
    Oncogene; 2017 Mar; 36(10):1328-1338. PubMed ID: 27593931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island.
    O'Hagan HM; Mohammad HP; Baylin SB
    PLoS Genet; 2008 Aug; 4(8):e1000155. PubMed ID: 18704159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive region-specific de novo methylation of the p16 CpG island in primary human mammary epithelial cell strains during escape from M(0) growth arrest.
    Wong DJ; Foster SA; Galloway DA; Reid BJ
    Mol Cell Biol; 1999 Aug; 19(8):5642-51. PubMed ID: 10409753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methyl-CpG binding domain protein 2 represses transcription from hypermethylated pi-class glutathione S-transferase gene promoters in hepatocellular carcinoma cells.
    Bakker J; Lin X; Nelson WG
    J Biol Chem; 2002 Jun; 277(25):22573-80. PubMed ID: 11960994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression.
    Eads CA; Danenberg KD; Kawakami K; Saltz LB; Danenberg PV; Laird PW
    Cancer Res; 1999 May; 59(10):2302-6. PubMed ID: 10344733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.